Pablo García-Pavía

Transthyretin amyloid cardiomyopathy

F. Domínguez, E. González-López, P. García-Pavía, 2021, Medicina Clínica (English Edition).

Case report: Alternative approach for management of refractory volume overload in heart failure: usefulness of venous leg compression

J. López-Azor, Pablo García-Pavía, Marta Cobo Marcos, 2023, Frontiers in cardiovascular medicine.

Alcoholic cardiomyopathy.

M. Cobo-Marcos, P. García-Pavía, María Gallego-Delgado, 2014, World journal of cardiology.

Extended septal myectomy versus alcohol septal ablation: clinical results at a national referral centre

C. Martín-López, J. Oteo-Domínguez, A. Forteza-Gil, 2024, Interdisciplinary cardiovascular and thoracic surgery.

Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM.

I. Olivotto, J. Januzzi, Amy Wohltman, 2024, Journal of the American College of Cardiology.

Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.

I. Olivotto, R. Barriales-Villa, M. Fifer, 2024, Journal of cardiac failure.

The role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy

Pablo García-Pavía, MD Fernando Dominguez, MD PhD Esther González-López, 2019 .

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy.

Carmen Munteanu, Pablo García-Pavía, Thibaud Damy, 2024, ESC heart failure.

Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.

C. Macrae, T. Ripoll-Vera, Pablo García-Pavía, 2024, ESC Heart Failure.

Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives.

J. Rodríguez-Palomares, M. Sabater-Molina, T. Ripoll-Vera, 2024, Journal of the American College of Cardiology.

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction.

E. Cariou, Ben Ebede, Pablo García-Pavía, 2024, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.

I. Olivotto, A. Sehnert, S. Saberi, 2024, JACC. Heart failure.

Prevalence of cardiac amyloidosis among elderly patients with recent-onset atrial fibrillation. The PREVAL-ATTR study.

Laroussi Mohamed-Salem, M. Gallego-Delgado, Paloma Remior-Perez, 2024, The Canadian journal of cardiology.

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy

R. Barriales-Villa, R. Gottlieb, Pablo García-Pavía, 2024, Circulation. Heart failure.